1 of 3
“The Global Implantable Medical Device Market to Grow USD 115,570.25 Million by 2025, at a CAGR of 6.68%”
FEATURED COMPANIES
- Abbott Laboratories
- C. R. Bard, Inc.
- Conmed Corporation
- Institut Straumann AG
- LivaNova PLC,
- Nuvasive, Inc.
- MORE
The Global Implantable Medical Device Market is expected to grow from USD 78,393.53 Million in 2019 to USD 115,570.25 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.68%.
Market Segmentation & Coverage:
This research report categorizes the Implantable Medical Device to forecast the revenues and analyze the trends in each of the following sub-markets:
On the basis of Product Type, the Implantable Medical Device Market is examined across Breast Implants, Cardiovascular Implants, Dental Implants, Facial Implants, Orthopedic Implants, and Intraocular lenses.
On the basis of Biologics, the Implantable Medical Device Market is examined across Biologics, Ceramics, Metals, and Polymers.
On the basis of End User, the Implantable Medical Device Market is examined across Ambulatory Surgery Centers, Clinics, and Hospitals.
On the basis of Geography, the Implantable Medical Device Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Implantable Medical Device Market including Abbott Laboratories, Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Conmed Corporation, Globus Medical, Inc., Institut Straumann AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova PLC,, Medtronic plc, Nuvasive, Inc., Smith & Nephew Plc, St. Jude Medical, Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Implantable Medical Device Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Implantable Medical Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Implantable Medical Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Implantable Medical Device Market?
4. What is the competitive strategic window for opportunities in the Global Implantable Medical Device Market?
5. What are the technology trends and regulatory frameworks in the Global Implantable Medical Device Market?
6. What are the modes and strategic moves considered suitable for entering the Global Implantable Medical Device Market?
Market Segmentation & Coverage:
This research report categorizes the Implantable Medical Device to forecast the revenues and analyze the trends in each of the following sub-markets:
On the basis of Product Type, the Implantable Medical Device Market is examined across Breast Implants, Cardiovascular Implants, Dental Implants, Facial Implants, Orthopedic Implants, and Intraocular lenses.
On the basis of Biologics, the Implantable Medical Device Market is examined across Biologics, Ceramics, Metals, and Polymers.
On the basis of End User, the Implantable Medical Device Market is examined across Ambulatory Surgery Centers, Clinics, and Hospitals.
On the basis of Geography, the Implantable Medical Device Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Implantable Medical Device Market including Abbott Laboratories, Biotronik, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Conmed Corporation, Globus Medical, Inc., Institut Straumann AG, Integra Lifesciences Holdings Corporation, Johnson & Johnson, LivaNova PLC,, Medtronic plc, Nuvasive, Inc., Smith & Nephew Plc, St. Jude Medical, Inc., Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Implantable Medical Device Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Implantable Medical Device Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Implantable Medical Device Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Implantable Medical Device Market?
4. What is the competitive strategic window for opportunities in the Global Implantable Medical Device Market?
5. What are the technology trends and regulatory frameworks in the Global Implantable Medical Device Market?
6. What are the modes and strategic moves considered suitable for entering the Global Implantable Medical Device Market?
Note: Product cover images may vary from those shown
2 of 3
FEATURED COMPANIES
- Abbott Laboratories
- C. R. Bard, Inc.
- Conmed Corporation
- Institut Straumann AG
- LivaNova PLC,
- Nuvasive, Inc.
- MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window
3. Executive Summary
3.1. Market Outlook
3.2. Product Type Outlook
3.3. Biologics Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Implantable Medical Device Market, By Geography
5. Market Dynamics
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Rising adoption of implantable medical devices by elderly population
5.1.1.2. Technological advancements in the field of implantable medical devices
5.1.1.3. Increasing government focus on funding R&D initiatives and better reimbursement policies
5.1.1.4. Rising number of FDA approvals for performing clinical trials
5.1.2. Restraints
5.1.2.1. Stringent approval process
5.1.2.2. Potential in the APAC region and developing countries due to improved infrastructure
5.1.2.3. Increasing awareness amongst patients for a better quality of life
5.1.2.4. Development of minimally invasive and non-surgical procedures
5.1.3. Opportunities
5.1.4. Challenges
5.1.4.1. High cost associated with the implantable medical devices
6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
7. Global Implantable Medical Device Market, By Product Type
7.1. Introduction
7.2. Breast Implants
7.3. Cardiovascular Implants
7.4. Dental Implants
7.5. Facial Implants
7.6. Orthopedic Implants
7.7. Intraocular lenses
8. Global Implantable Medical Device Market, By Biologics
8.1. Introduction
8.2. Biologics
8.3. Ceramics
8.4. Metals
8.5. Polymers
9. Global Implantable Medical Device Market, By End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Clinics
9.4. Hospitals
10. Americas Implantable Medical Device Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Implantable Medical Device Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. Europe, Middle East & Africa Implantable Medical Device Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Biotronik
14.3. Boston Scientific Corporation
14.4. C. R. Bard, Inc.
14.5. Cardinal Health, Inc.
14.6. Conmed Corporation
14.7. Globus Medical, Inc.
14.8. Institut Straumann AG
14.9. Integra Lifesciences Holdings Corporation
14.10. Johnson & Johnson
14.11. LivaNova PLC,
14.12. Medtronic plc
14.13. Nuvasive, Inc.
14.14. Smith & Nephew Plc
14.15. St. Jude Medical, Inc.
14.16. Stryker Corporation
14.17. Wright Medical Group N.V.
14.18. Zimmer Biomet Holdings, Inc.
15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
2.3.1. Competitive Strategic Window
3. Executive Summary
3.1. Market Outlook
3.2. Product Type Outlook
3.3. Biologics Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Implantable Medical Device Market, By Geography
5. Market Dynamics
5.1. Introduction
5.1.1. Drivers
5.1.1.1. Rising adoption of implantable medical devices by elderly population
5.1.1.2. Technological advancements in the field of implantable medical devices
5.1.1.3. Increasing government focus on funding R&D initiatives and better reimbursement policies
5.1.1.4. Rising number of FDA approvals for performing clinical trials
5.1.2. Restraints
5.1.2.1. Stringent approval process
5.1.2.2. Potential in the APAC region and developing countries due to improved infrastructure
5.1.2.3. Increasing awareness amongst patients for a better quality of life
5.1.2.4. Development of minimally invasive and non-surgical procedures
5.1.3. Opportunities
5.1.4. Challenges
5.1.4.1. High cost associated with the implantable medical devices
6. Market Insights
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations
7. Global Implantable Medical Device Market, By Product Type
7.1. Introduction
7.2. Breast Implants
7.3. Cardiovascular Implants
7.4. Dental Implants
7.5. Facial Implants
7.6. Orthopedic Implants
7.7. Intraocular lenses
8. Global Implantable Medical Device Market, By Biologics
8.1. Introduction
8.2. Biologics
8.3. Ceramics
8.4. Metals
8.5. Polymers
9. Global Implantable Medical Device Market, By End User
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Clinics
9.4. Hospitals
10. Americas Implantable Medical Device Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Implantable Medical Device Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. Europe, Middle East & Africa Implantable Medical Device Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. Biotronik
14.3. Boston Scientific Corporation
14.4. C. R. Bard, Inc.
14.5. Cardinal Health, Inc.
14.6. Conmed Corporation
14.7. Globus Medical, Inc.
14.8. Institut Straumann AG
14.9. Integra Lifesciences Holdings Corporation
14.10. Johnson & Johnson
14.11. LivaNova PLC,
14.12. Medtronic plc
14.13. Nuvasive, Inc.
14.14. Smith & Nephew Plc
14.15. St. Jude Medical, Inc.
14.16. Stryker Corporation
14.17. Wright Medical Group N.V.
14.18. Zimmer Biomet Holdings, Inc.
15. Appendix
15.1. Discussion Guide
15.2. Edition Details
15.3. License Details
15.4. Pricing Details
Note: Product cover images may vary from those shown
3 of 3
- Abbott Laboratories
- Biotronik
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cardinal Health, Inc.
- Conmed Corporation
- Globus Medical, Inc.
- Institut Straumann AG
- Integra Lifesciences Holdings Corporation
- Johnson & Johnson
- LivaNova PLC,
- Medtronic plc
- Nuvasive, Inc.
- Smith & Nephew Plc
- St. Jude Medical, Inc.
- Stryker Corporation
- Wright Medical Group N.V.
- Zimmer Biomet Holdings, Inc.
Note: Product cover images may vary from those shown
